Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension
Phase 2
Completed
- Conditions
- Hypertension
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2009-01-30
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00160212
- Locations
- 🇭🇺
Site 805, Budapest, Hungary
🇧🇬Site 957, Sofia, Bulgaria
🇭🇺Site 804, Pecs, Hungary
Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
Phase 3
Terminated
- Conditions
- Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
- Interventions
- Drug: Placebo
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2015-02-09
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 60
- Registration Number
- NCT00160147
- Locations
- 🇺🇸
Site 910, Santa Ana, California, United States
🇺🇸Site 902, Carson, California, United States
🇺🇸Site 911, Pasadena, California, United States
Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure
Phase 2
Completed
- Conditions
- Congestive Heart Failure
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2009-01-30
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00160134
- Locations
- 🇩🇪
Site 1, Bad Nauheim, Germany
Study to Investigate if Adding Lactulose to Vitamin D and Calcium Has an Effect on the Preservation of Bone in Postmenopausal Women
Phase 4
Completed
- Conditions
- Osteopenia
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2009-01-30
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 40
- Registration Number
- NCT00160264
- Locations
- 🇪🇸
Site 3, Barcelona, Spain
🇪🇸Site 2, Barcelona, Spain
🇪🇸Site 1, Barcelona, Spain
Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes
Not Applicable
Completed
- Conditions
- HypertensionType 2 Diabetes
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2009-01-30
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 440
- Registration Number
- NCT00160160
- Locations
- 🇳🇴
Site 41, Skedsmokorset, Norway
🇳🇴Site 44, Horten, Norway
🇳🇴Site 43, Alesund, Norway
Efficacy and Safety of Moxonidine in Indian Patients
Phase 3
Completed
- Conditions
- Hypertension
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2009-01-30
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 100
- Registration Number
- NCT00160277
- Locations
- 🇮🇳
Site 3, New Delhi, India
🇮🇳Site 1, Jubillee Hills Hyderabad, India
🇮🇳Site 2, Mangalore, India
Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion
Phase 4
Completed
- Conditions
- Secondary Amenorrhea
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2010-07-07
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 240
- Registration Number
- NCT00160199
- Locations
- 🇺🇸
Site 7, Baltimore, Maryland, United States
🇺🇸Site 16, Reno, Nevada, United States
🇺🇸Site 14, Aventura, Florida, United States
Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes
Phase 2
Completed
- Conditions
- Hot Flushes, Menopause, Postmenopause
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-08-15
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 1251
- Registration Number
- NCT00160342
- Locations
- 🇺🇸
Site 42, Virginia Beach, Virginia, United States
🇺🇸Site 14, Waterbury, Connecticut, United States
🇺🇸Site 4, Groton, Connecticut, United States
Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Having Undergone Vestibular Neurotomy
Phase 4
Completed
- Conditions
- Meniere's Disease
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2006-12-22
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 20
- Registration Number
- NCT00160238
- Locations
- 🇫🇷
Site 1, Marseille, France
Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension
Phase 2
Completed
- Conditions
- Hypertension
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2007-11-14
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00160225
- Locations
- 🇮🇹
Site 1, Ranica, Italy
© Copyright 2025. All Rights Reserved by MedPath